I found this statement to be quite interesting in its numerous implications:
First author Mark Christiansen, MD, Leslie Klaff, MD, and colleagues added: "The results from this study demonstrate that the use of a long-term, 90-day, implantable continuous glucose sensor is accurate and safe with high rates of adherence to use.
“Additional clinical studies will be required to evaluate the accuracy and usability of the Eversense CGM system among pediatrics, with reduced calibration frequency, and for extended durations through 180 days.”